Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.65 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.65 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.65 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.65 |
| ▸ | DRD2 | P14416 | 3/20 | 0.65 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.65 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.65 |
| ▸ | HTR2A | P28223 | 3/20 | 0.65 |
| ▸ | HRH1 | P35367 | 3/20 | 0.65 |
| ▸ | DRD3 | P35462 | 3/20 | 0.65 |
| ▸ | HTR2B | P41595 | 3/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1137978 | 1.00 | LMNA (0.65) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1137980 | 1.00 | LMNA (0.65) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1138126 | 0.95 | LMNA (0.70) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1138128 | 0.95 | LMNA (0.70) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL6554386 | 0.85 | LMNA (0.65) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1137906 | 0.85 | SLC6A9 (0.57) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1137901 | 0.85 | SLC6A9 (0.57) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1137893 | 0.85 | OPRD1 (0.68) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1137896 | 0.85 | OPRD1 (0.68) | LMNAMEN1KMT2AHIF1AOPRM1 | |
| SCHEMBL1138520 | 0.81 | KCNH2 (0.59) | LMNAMEN1KMT2AHIF1AOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1487810-A2 | 4-(DIARYLMETHYL)-1-PIPERAZINYL DERIVATIVES | Sun Pharmaceuticals Industries Ltd. (IN) | 2004-12-22 | — | — | EP | claimed |
| WO-2003079970-A2 | 4-(DIARYLMETHYL)-1-PIPERAZINYL DERIVATIVES | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2003-10-02 | — | — | WO | claimed |
| EP-1487810-B9 | 4-(DIARYLMETHYL)-1-PIPERAZINYL DERIVATIVES | SUN PHARMA ADVANCED RES CO LTD (IN) | 2011-02-23 | — | — | EP | disclosed |
| EP-1487810-B1 | 4-(DIARYLMETHYL)-1-PIPERAZINYL DERIVATIVES | SUN PHARMA ADVANCED RES CO LTD (IN) | 2010-02-17 | — | — | EP | disclosed |
| US-7297697-B2 | with alkenyl moiety substituted at the 1-position of the piperazine unit; useful in the treatment of histamine mediated diseases | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2007-11-20 | — | — | US | disclosed |
| US-20050107393-A1 | 4-(diarylmethyl)-1-piperazinyl derivatives | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2005-05-19 | — | — | US | disclosed |
| EP-1487810-A2 | 4-(DIARYLMETHYL)-1-PIPERAZINYL DERIVATIVES | Sun Pharmaceuticals Industries Ltd. (IN) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003079970-A2 | 4-(DIARYLMETHYL)-1-PIPERAZINYL DERIVATIVES | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2003-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107393-A1 | 4-(diarylmethyl)-1-piperazinyl derivatives | NPY2R, NPY1R, CBR3 | LMNA 1681/4885MEN1 2759/4885KMT2A 3606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.